Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trends in lipid-modifying agent use in 83 countries
Joseph E. Blais, Yue Wei, Kevin K.W. Yap, et al.
Atherosclerosis (2021) Vol. 328, pp. 44-51
Open Access | Times Cited: 82

Showing 26-50 of 82 citing articles:

Effects of the July 2018 worldwide valsartan recall and shortage on global trends in antihypertensive medication use: a time-series analysis in 83 countries
Yuna Choi, Araniy Santhireswaran, Cherry Chu, et al.
BMJ Open (2023) Vol. 13, Iss. 1, pp. e068233-e068233
Open Access | Times Cited: 9
Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research
Sanjana Misra, Tanica Lyngdoh, Rubina Mulchandani
Indian Heart Journal (2022) Vol. 74, Iss. 5, pp. 341-350
Open Access | Times Cited: 14
The Impact of Drugs on Hydrogen Sulfide Homeostasis in Mammals
Asrar Alsaeedi, Simon Welham, Peter Rose, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 908-908
Open Access | Times Cited: 8
Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin
Hilal Kalkan, Elisabetta Panza, Ester Pagano, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 8
Systematic Review and Meta-Analysis of the Effect of Statins on Circulating E-Selectin, L-Selectin, and P-Selectin
Angelo Zinellu, Arduino A. Mangoni
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1707-1707
Open Access | Times Cited: 18
Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Joseph E. Blais, Xin Huang, Jie Zhao
Drugs (2023) Vol. 83, Iss. 5, pp. 403-427
Open Access | Times Cited: 7
Statins
Spoorthy Kulkarni, Michaela Watts, Michael S. Kostapanos
BMJ (2024), pp. e072584-e072584
Closed Access | Times Cited: 2
Association between Statins Administration and Influenza Susceptibility: A Systematic Review and Meta-Analysis of Longitudinal Studies
Fan Wu, Congcong Wang, S J Li, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 278-278
Open Access | Times Cited: 2
Decoding the Intricacies of Statin-Associated Muscle Symptoms
Tara Fallah Rastegar, Imtiaz Ahmed Khan, Lisa Christopher‐Stine
Current Rheumatology Reports (2024) Vol. 26, Iss. 7, pp. 260-268
Closed Access | Times Cited: 2
A pharmacovigilance study of chronic kidney disease in diabetes mellitus patients with statin treatment by using the US Food and Drug Administration adverse event reporting system
Jingyi Zhang, Yuting Guo, Chunyan Wei, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Facts and ideas on statins with respect to their lipophilicity: a focus on skeletal muscle cells and bone besides known cardioprotection
A. Švec, Adriana Adameová
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 8, pp. 1661-1667
Open Access | Times Cited: 11
Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance
Zsuzsanna Schelz, Hiba F. Muddather, István Zupkó
Antibiotics (2023) Vol. 12, Iss. 9, pp. 1468-1468
Open Access | Times Cited: 6
Biological Actions, Implications, and Cautions of Statins Therapy in COVID-19
Chengyu Liu, Wanyao Yan, Jiajian Shi, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 9
Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease
Lijun Zhu, Yangliang Fang, Beibei Gao, et al.
BMC Cardiovascular Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis
Kuan Peng, Joseph E. Blais, Nicole Pratt, et al.
BioDrugs (2023) Vol. 37, Iss. 3, pp. 409-420
Open Access | Times Cited: 5
Comparative efficacy and safety of statin and fibrate monotherapy: A systematic review and meta-analysis of head-to-head randomized controlled trials
Joseph E. Blais, Gloria Kin Yi Tong, Swathi Pathadka, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0246480-e0246480
Open Access | Times Cited: 12
Trends in PCSK9 inhibitor utilization in the United States, Europe, and other countries: An analysis of international sales data
Joseph E. Blais, Yue Wei, Martín Knapp, et al.
American Heart Journal (2022) Vol. 248, pp. 13-20
Open Access | Times Cited: 8
Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population
Mais N. Alqasrawi, Zeina N. Al-Mahayri, Hiba Alblooshi, et al.
Current Vascular Pharmacology (2024) Vol. 22, Iss. 3, pp. 218-229
Closed Access | Times Cited: 1
Statin Drug‐Drug Interactions: Pharmacokinetic Basis of FDA Labeling Recommendations and Comparison Across Common Tertiary Clinical Resources
James Mease, Anuradha Ramamoorthy, Xinning Yang, et al.
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 6, pp. 704-712
Closed Access | Times Cited: 1
Persistence to statin treatment: A cohort study in Lithuania
Karina Kirilova, Indrė Trečiokienė, Nomeda Bratčikovienė, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 1, pp. 43-51
Open Access | Times Cited: 1
Acceleration of HDL-Mediated Cholesterol Efflux Alleviates Periodontitis
Thi-Thao Tran, Gary Lee, Yun Hyun Huh, et al.
Journal of Dental Research (2024)
Closed Access | Times Cited: 1
Statin, Ezetimibe, or Fibrate Initiation and Subsequent Use for the Primary and Secondary Prevention of Cardiovascular Diseases among Japanese Patients Aged ≥55 Years: A Nationwide Cohort Study
Junko Tomida, Tsugumichi Sato, Tomoji Yoshida, et al.
Biological and Pharmaceutical Bulletin (2023) Vol. 46, Iss. 11, pp. 1548-1557
Open Access | Times Cited: 3
Impact of the COVID-19 pandemic on antidepressant and antipsychotic use among children and adolescents: a population-based study
Tony Antoniou, Kathleen Pajer, William Gardner, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 3
Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates
Zeina N. Al-Mahayri, Lubna Q. Khasawneh, Mais N. Alqasrawi, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Association between statins and the risk of suicide attempt, depression, anxiety, and seizure: A population-based, self-controlled case series study
Xuxiao Ye, Joseph E. Blais, V Ng, et al.
Journal of Affective Disorders (2022) Vol. 320, pp. 421-427
Open Access | Times Cited: 5

Scroll to top